ECP
NEUE

Empyrean Capital Partners’s NeueHealth NEUE Stock Holding History

Empyrean Capital Partners’s Portfolio NEUE Stock Details NEUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,250
Closed -$1.72M – 199
2021
Q2 		$1.72M Buy
+1,250
New +$1.71M 0.04% 152

Other funds holding NEUE

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
DIC
Deer IX & Co Larchmont, New York $971M AUM 24.77% 1-Year Est. Return
SG
StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $24B AUM 39.59% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
PGH
Partners Group Holding Baar-Zug, Switzerland $1.47B AUM 8.59% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $170M AUM 34.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Empyrean Capital Partners's NEUE Position: Q3 2021 in Review

Empyrean Capital Partners sold out of NeueHealth (NEUE) in Q3 2021, closing a stake of 1,250 shares — an estimated $1.72M sold.

Empyrean Capital Partners first reported a position in NEUE in Q2 2021 and held it in 1 quarter. The position peaked at $1.72M in Q2 2021. 102 funds tracked by Wall St. Rank hold NEUE as of Q3 2021.

  • Empyrean Capital Partners reported no remaining NeueHealth position as of Q3 2021 after selling out during the quarter.
  • Empyrean Capital Partners sold 1,250 NeueHealth shares in Q3 2021, an estimated $1.72M.
  • Empyrean Capital Partners first reported a position in NeueHealth in Q2 2021 and held it in 1 quarter.
  • Empyrean Capital Partners's NeueHealth position peaked at $1.72M in Q2 2021.
  • 102 funds tracked by Wall St. Rank held NeueHealth as of Q3 2021.

Based on Empyrean Capital Partners's 13F filing for Q3 2021, filed 15 Nov 2021.